Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v14-EN | Version v4-EN | |
---|---|---|
Language | English | English |
Date Updated | 2023-10-02 | 2023-01-03 |
Drug Identification Number | 00035017 | 00035017 |
Brand name | ALCON ATROPINE | ALCON ATROPINE |
Common or Proper name | ISOPTO ATROPINE 1% 5ML-CDN | ISOPTO ATROPINE 1% 5ML-CDN |
Company Name | ALCON CANADA INC | ALCON CANADA INC |
Ingredients | ATROPINE SULFATE | ATROPINE SULFATE |
Strength(s) | 1% | 1% |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | OPHTHALMIC OPHTHALMIC | OPHTHALMIC OPHTHALMIC |
Packaging size | 5ml | 5ml |
ATC code | S01FA | S01FA |
ATC description | MYDRIATICSAND CYCLOPLEGICS | MYDRIATICSAND CYCLOPLEGICS |
Reason for shortage | Requirements related to complying with good manufacturing practices. | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2022-11-08 | 2022-11-08 |
Actual start date | 2022-11-08 | 2022-11-08 |
Estimated end date | 2023-09-30 | 2023-01-31 |
Actual end date | 2023-09-24 | |
Shortage status | Resolved | Actual shortage |
Tier 3 Status | No | No |
Company comments | ||
Health Canada comments |